History of myocardial infarction.

History of stroke.

Heart failure.

Endocrine organ disease.

Lung disease.

Clinically significant abnormal biochemical screening of the blood regarding: B-hemoglobin, P-sodium, P-potassium, P-creatinine (under 200 µmol/L will be accepted), P-albumin, p-bilirubin, p-alaninaminotransferase, P-alkaline phosphatase, p-cholesterol and B-glucose.

Clinically significant abnormal screening of the urine regarding: albumin and glucose (protein excretion below 0.5 g/L will be accepted).

Renovascular hypertension.

Malignant disease.

Alcohol abuse.

Usage of medical drugs besides antihypertensives or statins.

Drug abuse.

Pregnancy or breast feeding.

Known intolerance or allergic to eprosartan or sodium nitroprusside.

Blood donation within 1 month of the start of the study.

The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension

What this study is about